Posted by Michael Wonder on 17 Jul 2025
US FDA approves GSK’s Shingrix in a pre-filled syringe presentation
17 July 2025 - Pre-filled syringe presentation offers a convenient administration option to health care professionals.
GSK today announced that the US FDA) has approved a pre-filled syringe presentation of Shingrix (GSK’s recombinant zoster vaccine) for the prevention of shingles (herpes zoster).
